| Nanotechnologies for biomolecular detection and medical diagnostics MMC Cheng, G Cuda, YL Bunimovich, M Gaspari, JR Heath, HD Hill, ... Current opinion in chemical biology 10 (1), 11-19, 2006 | 630 | 2006 |
| Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma G Pelaia, A Vatrella, MT Busceti, L Gallelli, C Calabrese, R Terracciano, ... Mediators of inflammation 2015 (1), 879783, 2015 | 285 | 2015 |
| The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A … L Gallelli, O Galasso, D Falcone, S Southworth, M Greco, V Ventura, ... Osteoarthritis and cartilage 21 (9), 1400-1408, 2013 | 172 | 2013 |
| Benralizumab: from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma C Pelaia, C Calabrese, A Vatrella, MT Busceti, E Garofalo, N Lombardo, ... BioMed research international 2018 (1), 4839230, 2018 | 141 | 2018 |
| Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness C Pelaia, C Calabrese, R Terracciano, F de Blasio, A Vatrella, G Pelaia Therapeutic advances in respiratory disease 12, 1753466618810192, 2018 | 135 | 2018 |
| Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab C Pelaia, A Vatrella, MT Busceti, L Gallelli, R Terracciano, R Savino, ... Drug design, development and therapy, 3137-3144, 2017 | 105 | 2017 |
| Selective binding and enrichment for low‐molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles R Terracciano, M Gaspari, F Testa, L Pasqua, P Tagliaferri, MMC Cheng, ... Proteomics 6 (11), 3243-3250, 2006 | 103 | 2006 |
| Molecular targets for biological therapies of severe asthma C Pelaia, C Crimi, A Vatrella, C Tinello, R Terracciano, G Pelaia Frontiers in immunology 11, 603312, 2020 | 100 | 2020 |
| The proteomics big challenge for biomarkers and new drug-targets discovery R Savino, S Paduano, M Preianò, R Terracciano International journal of molecular sciences 13 (11), 13926-13948, 2012 | 92 | 2012 |
| Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma M Gaspari, M Ming-Cheng Cheng, R Terracciano, X Liu, AJ Nijdam, ... Journal of proteome research 5 (5), 1261-1266, 2006 | 92 | 2006 |
| Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non‐small lung cancer cells G Pelaia, L Gallelli, T Renda, D Fratto, D Falcone, M Caraglia, MT Busceti, ... Cell proliferation 45 (6), 557-565, 2012 | 87 | 2012 |
| Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: results of a single-centre observational … C Pelaia, MT Busceti, S Solinas, R Terracciano, G Pelaia Pulmonary pharmacology & therapeutics 53, 1-5, 2018 | 71 | 2018 |
| Benralizumab in the treatment of severe asthma: design, development and potential place in therapy C Pelaia, A Vatrella, A Bruni, R Terracciano, G Pelaia Drug design, development and therapy, 619-628, 2018 | 70 | 2018 |
| Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: assessment of blood eosinophils, symptom control, lung function and oral … C Pelaia, MT Busceti, A Vatrella, GF Rago, C Crimi, R Terracciano, ... Pulmonary Pharmacology & Therapeutics 58, 101830, 2019 | 64 | 2019 |
| Peptidome profiling of induced sputum by mesoporous silica beads and MALDI‐TOF MS for non‐invasive biomarker discovery of chronic inflammatory lung diseases R Terracciano, M Preianò, GP Palladino, GE Carpagnano, MPF Barbaro, ... Proteomics 11 (16), 3402-3414, 2011 | 64 | 2011 |
| Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells C Celia, N Malara, R Terracciano, D Cosco, D Paolino, M Fresta, ... Nanomedicine: Nanotechnology, Biology and Medicine 4 (2), 155-166, 2008 | 64 | 2008 |
| Role of biologics in severe eosinophilic asthma–focus on reslizumab G Pelaia, A Vatrella, MT Busceti, L Gallelli, M Preianò, N Lombardo, ... Therapeutics and Clinical Risk Management, 1075-1082, 2016 | 61 | 2016 |
| Lycopene and bone: An in vitro investigation and a pilot prospective clinical study C Russo, Y Ferro, S Maurotti, MA Salvati, E Mazza, R Pujia, R Terracciano, ... Journal of translational medicine 18, 1-11, 2020 | 55 | 2020 |
| Asthma and COPD proteomics: current approaches and future directions R Terracciano, G Pelaia, M Preianò, R Savino PROTEOMICS–Clinical Applications 9 (1-2), 203-220, 2015 | 55 | 2015 |
| Dupilumab for the treatment of asthma C Pelaia, A Vatrella, L Gallelli, R Terracciano, P Navalesi, R Maselli, ... Expert opinion on biological therapy 17 (12), 1565-1572, 2017 | 52 | 2017 |
